(Q35987482)

English

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

pituitary adenoma

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Jean Christophe Maiza

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Delphine Vezzosi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maria Matta

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Florence Donadille

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Florence Loubes-Lacroix

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Antoine Bennet

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Philippe Caron

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 May 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Clinical Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

67

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

282-289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Pituitary radiotherapy: current controversies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

The place of pegvisomant in the acromegaly treatment algorithm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Guidelines for acromegaly management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

2 October 2017

Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

11 July 2018

Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Cabergoline in the treatment of acromegaly: a study in 64 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.02878.X

21 January 2018

Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1974833

24 September 2018

Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year follow-up results of transsphenoidal microsurgery in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing mortality in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphological effects of octreotide on growth hormone-producing pituitary adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The volume of the sella turcica

1 reference

https://pubmed.ncbi.nlm.nih.gov/17524029

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2265.2007.02878.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17524029%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35987482&oldid=1965776552"